MARKET

RGEN

RGEN

Repligen
NASDAQ
130.57
-3.08
-2.30%
Opening 13:31 02/27 EST
OPEN
132.71
PREV CLOSE
133.65
HIGH
133.94
LOW
128.25
VOLUME
325.42K
TURNOVER
--
52 WEEK HIGH
175.77
52 WEEK LOW
102.97
MARKET CAP
7.35B
P/E (TTM)
151.05
1D
5D
1M
3M
1Y
5Y
1D
Oversold Conditions For Repligen (RGEN)
NASDAQ · 6h ago
How Investors Are Reacting To Repligen (RGEN) Earnings Beat Paired With Cautious 2026 Guidance
Simply Wall St · 16h ago
Analysts Have Conflicting Sentiments on These Healthcare Companies: Amarin (AMRN), Ionis Pharmaceuticals (IONS) and Repligen (RGEN)
TipRanks · 1d ago
Assessing Repligen (RGEN) After Prolonged Share Price Weakness
Simply Wall St · 1d ago
Repligen Is Maintained at Buy by UBS
Dow Jones · 2d ago
Repligen Price Target Cut to $195.00/Share From $200.00 by UBS
Dow Jones · 2d ago
UBS Maintains Buy on Repligen, Lowers Price Target to $195
Benzinga · 2d ago
A Glimpse Into The Expert Outlook On Repligen Through 6 Analysts
Benzinga · 2d ago
More
About RGEN
Repligen Corporation is a global life sciences company that develops and commercializes bioprocessing technologies and systems. Its focus areas are Filtration and Fluid Management, Chromatography, Process Analytics and Proteins. Its filtration products are used in process development and process scale (clinical and commercial) production. Its XCell ATF systems are used in upstream perfusion (continuous) and N-1 (intensified fed-batch or hybrid perfusion) cell culture processing. Its chromatography franchise includes several products used in downstream purification, development, manufacturing and quality control of biological drugs. Its process analytics products complement and support its filtration, chromatography and protein franchises. Its TangenX product portfolio includes flat sheet (FS) tangential flow filtration (TFF) cassettes used primarily in downstream and ultrafiltration processes. Its desktop portfolio includes MAVERICK and MAVEN, REBEL, and ZipChip.

Webull offers Repligen Corp stock information, including NASDAQ: RGEN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RGEN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RGEN stock methods without spending real money on the virtual paper trading platform.